.jpg "Cipla To Enter India's Weight Management Market Amid Rising Demand")
Pharma major Cipla is preparing to enter India's weight management space as a part of its strategy to leverage emerging healthcare opportunities and niche therapy opportunities.
An organization that promotes exports stated that a new law that centralizes the licensing procedure for medicine exports through a web portal might reduce shipments by over 45%, asking for time to transition to the new system.
.jpeg "Maharashtra's COVID-19 Tally Rises to 2,620 as Mumbai Sees Fresh Cases")
Maharashtra reported a slight rise in fresh COVID-19 cases as the state recorded seven new cases on Friday, bringing the number of cases since January 1 to 2,620. Mumbai remains the primary area of the outbreak, recording four of the new cases...
India’s pharmaceutical sector is focused on a major goal of increasing exports to USD 1 trillion, and biosimilars are emerging as the cornerstone of this growth. Currently valued at USD 50–55 billion, pharmaceutical exports from India are expected...
In a bold strategic shift, Wockhardt has divested its U.S. generics business to focus on high-value, innovative therapies, including novel antibiotics and biologics. The company announced the voluntary liquidation of Wockhardt USA LLC and Morton...
In an ambitious step to transform India's healthcare system, the Adani Group announced that they are developing two AI-first Health Cities in Ahmedabad and Mumbai, with an initial investment of ?6,000 crore. The Cities will integrate healthcare...
Apollo AyurVAID, a part of Apollo Hospitals Group, has announced the launch of India’s First line of “Tested Safe” Ayurveda products, setting a new benchmark in the traditional medicine space. The line includes classical prescription formulations...
Meril, a global leader in advanced medical solutions, successfully concluded its flagship “TechVentory” program across Delhi, Mumbai, and Kochi. The event brought together over 100 senior procurement and supply chain executives from leading...
The Indian Institute of Management Ahmedabad (IIMA) and Novo Nordisk India Pvt Ltd (NNIPL) has inked a Memorandum of Understanding (MoU) to advance a strategic partnership for five years, until 2030.
In a landmark move for India's biopharma industry, Ichnos Glenmark Innovation (IGI)—a partnership between Glenmark Pharmaceuticals and Ichnos Sciences—has signed a USD 2 billion licensing deal with AbbVie, a leading US pharmaceutical company...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")